Showing results (61-70 of 74) with videos related to
Sort By:
Pageof 8
Mbio|November 10, 2022
Genomic Variation across a Clinical Cryptococcus Population Linked to Disease OutcomePoppy Sephton-Clark, Jennifer L Tenor, Dena L Toffaletti, et al.Mbio|August 27, 2024
Integration of genomic and pharmacokinetic data to predict clinical outcomes in HIV-associated cryptococcal meningitisKatharine E Stott, Jason T Mohabir, Katharine Bowers, et al.The Journal of Antimicrobial Chemotherapy|November 21, 2022
Population pharmacokinetics of liposomal amphotericin B in adults with HIV-associated cryptococcal meningoencephalitisKatharine E Stott, Melanie Moyo, Ajisa Ahmadu, et al.BMC Medicine|March 29, 2022
AstraZeneca COVID-19 vaccine induces robust broadly cross-reactive antibody responses in Malawian adults previously infected with SARS-CoV-2Marah G Chibwana, Thandeka Moyo-Gwete, Gaurav Kwatra, et al.Nature Communications|December 15, 2025
Persistent pneumococcal colonisation in antiretroviral-treated HIV infection is associated with nasal inflammationJoseph Aston Phiri, Lusako Lucky Sibale, Gloria Kapira, et al.Nature Communications|June 12, 2021
Distinct clinical and immunological profiles of patients with evidence of SARS-CoV-2 infection in sub-Saharan AfricaBen Morton, Kayla G Barnes, Catherine Anscombe, et al.Medrxiv : the Preprint Server for Health Sciences|August 9, 2020
High SARS-CoV-2 seroprevalence in health care workers but relatively low numbers of deaths in urban MalawiMarah G Chibwana, Khuzwayo C Jere, Raphael Kamn'gona, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 3, 2025
Recent Antiretroviral Therapy Initiation Is Associated With Increased Mortality Risk in HIV-associated Cryptococcal Meningitis: An Analysis of Clinical Trial Data From AfricaMelanie Moyo, David S Lawrence, James Jafali, et al.The Lancet. Global Health|April 27, 2025
Personalised risk-prediction tools for cryptococcal meningitis mortality to guide treatment stratification in sub-Saharan Africa: a prognostic modelling study based on pooled analysis of two randomised controlled trialsThomas H A Samuels, Sile F Molloy, David S Lawrence, et al.Trials|January 16, 2019
Correction to: AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority TrialDavid S Lawrence, Nabila Youssouf, Síle F Molloy, et al.Pageof 8